For instance, PI3K/AKT activation was considered a major mechanism for failure of combined bortezomib/ABT-737 to drive apoptosis in glioma cells, particularly those with PTEN mutations (eg, U87MG) [95]. This evidence concerns the gene AKT1 and glioma.